Translational genomics and recent advances in oral squamous cell carcinoma
- PMID: 31542510
- DOI: 10.1016/j.semcancer.2019.09.011
Translational genomics and recent advances in oral squamous cell carcinoma
Abstract
Oral squamous cell carcinomas (OSCC) are a heterogeneous group of cancers arising from the mucosal lining of the oral cavity. A majority of these cancers are associated with lifestyle risk habits including smoking, excessive alcohol consumption and betel quid chewing. Cetuximab, targeting the epidermal growth factor receptor was approved for the treatment of OSCC in 2006, and remains the only molecular targeted therapy available for OSCC. Here, we reviewed the current findings from genomic analyses of OSCC and discuss how these studies inform on the biological mechanisms underlying OSCC. Exome sequencing revealed that the significantly mutated genes are mainly tumour suppressors. Mutations in FAT1, CASP8, CDKN2A, and NOTCH1 are more frequently found in OSCC when compared to non-OSCC head and neck cancers and other squamous cell carcinomas, and HRAS and PIK3CA are the only significantly mutated oncogenes. The distribution of these mutations also differs in populations with distinct risk habits. Gene expression-based molecular classification showed that OSCC can be divided into distinct subtypes and these have a preferential response to different types of therapies, suggesting that these classifications could have clinical implications. More recently, with the approval of checkpoint inhibitors for the treatment of cancers including OSCC, genomics studies also dissected the genetic signatures of the immune compartment to delineate immune-active and -exhausted subtypes that could inform on the immune status of OSCC patients and guide the development of novel therapies to improve response to immunotherapy. Taken together, genomics studies are informing on the biology of both the epithelial and stromal compartments underlying OSCC development, and we discuss the opportunities and challenges in using these to derive clinical benefit for OSCC patients.
Keywords: Head and neck squamous cell carcinoma; Immune subtypes; Molecular classification; Oral squamous cell carcinoma; Translational genomics.
Copyright © 2019. Published by Elsevier Ltd.
Similar articles
-
Targeting the DNA Damage Response in OSCC with TP53 Mutations.J Dent Res. 2018 Jun;97(6):635-644. doi: 10.1177/0022034518759068. Epub 2018 Feb 28. J Dent Res. 2018. PMID: 29489434 Free PMC article. Review.
-
Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.Theranostics. 2017 Feb 26;7(5):1088-1099. doi: 10.7150/thno.18551. eCollection 2017. Theranostics. 2017. PMID: 28435450 Free PMC article.
-
Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.Cancer Lett. 2016 Dec 1;383(1):106-114. doi: 10.1016/j.canlet.2016.09.014. Epub 2016 Sep 28. Cancer Lett. 2016. PMID: 27693639 Free PMC article.
-
Roles of FGFR in oral carcinogenesis.Cell Prolif. 2016 Jun;49(3):261-9. doi: 10.1111/cpr.12260. Cell Prolif. 2016. PMID: 27218663 Free PMC article. Review.
-
Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.Oncotarget. 2016 May 10;7(19):27802-18. doi: 10.18632/oncotarget.8533. Oncotarget. 2016. PMID: 27050151 Free PMC article.
Cited by
-
METTL3 Promotes OSCC Progression by Down-Regulating WEE1 in a m6A-YTHDF2-Dependent Manner.Mol Biotechnol. 2024 May 14. doi: 10.1007/s12033-024-01165-y. Online ahead of print. Mol Biotechnol. 2024. PMID: 38744787
-
Toll-like receptors in health and disease.MedComm (2020). 2024 Apr 29;5(5):e549. doi: 10.1002/mco2.549. eCollection 2024 May. MedComm (2020). 2024. PMID: 38685971 Free PMC article. Review.
-
Antiapoptotic PON2 expression and its clinical implications in locally advanced oral squamous cell carcinoma.Cancer Sci. 2024 Jun;115(6):2012-2022. doi: 10.1111/cas.16170. Epub 2024 Apr 11. Cancer Sci. 2024. PMID: 38602182 Free PMC article.
-
Higher overall survival rates of oral squamous cell carcinoma treated with metronomic neoadjuvant chemotherapy.Am J Cancer Res. 2024 Mar 15;14(3):1033-1051. doi: 10.62347/EYNT8387. eCollection 2024. Am J Cancer Res. 2024. PMID: 38590400 Free PMC article.
-
Association between Vitamin D Receptor Polymorphism and Susceptibility to Oral Lichen Planus and Oral Squamous Cell Carcinoma.Iran J Otorhinolaryngol. 2024 Mar;36(2):381-389. doi: 10.22038/IJORL.2024.73925.3489. Iran J Otorhinolaryngol. 2024. PMID: 38476562 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous